This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources Aug. 24, 2010
ASCLS eNewsBytes
Aug. 24, 2010
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

More egg recalls could be ahead, FDA chief says
More egg recalls could be ahead, FDA chief says    Share   Share on FacebookTwitterShare on LinkedinE-mail article
The recall of more than half a billion eggs over the past two weeks is the "largest such egg recall in recent history" and the Food and Drug Administration "may need to continue with smaller subrecalls," FDA Commissioner Margaret Hamburg said on CNN's "American Morning." Hillandale Farms of Iowa announced it was recalling more than 170 million eggs. Another 380 million have been recalled by another Iowa producer, Wright County Egg, after the FDA linked the eggs to an outbreak of salmonella that has sickened hundreds of people nationwide.

New troponin recommendations should bridge gap between lab and clinic
Heartwire via Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cardiac troponin is a "crucial marker" of acute MI and should be used for risk stratification, but it can also be released in clinical conditions other than AMI, say Dr. Kristian Thygesen (Aarhus University Hospital, Denmark) and colleagues, who have published new recommendations on how doctors should use troponin to guide cardiac care. The guidance is the first in a series of three on biomarkers, Thygesen told heartwire , with other documents on B-type natriuretic peptide (BNP) and C-reactive protein (CRP) due to follow from the same European Society of Cardiology Working Group on Acute Cardiac Care. "Clinicians do not fully understand how to handle troponin, so we developed this to help them. This is designed to fill in the vacuum between the lab people and clinicians," he explained. More

More community hospital pathology laboratories are ready to tackle molecular testing for infectious disease and cancer
DARK Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Because of advances in automated molecular systems and less complex technologies, it is now possible for more clinical pathology laboratories in community hospitals to establish their own molecular diagnostics testing program. This is particularly true of testing for infectious disease and cancer. At the same time that local pathology and clinical laboratories have this opportunity to provide useful new molecular and genetic tests to physicians in their community, questions often remain about how to assess the clinical value of performing a molecular diagnostic test versus the cost of performing that assay. More

Ovarian cryopreservation may be unsafe in leukemia patients
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Ovarian tissue cryopreservation is a relatively new option for cancer patients who wish to preserve fertility prior to undergoing chemotherapy and radiotherapy. But even though autotransplantation of frozen–thawed ovarian tissue harvested before chemotherapy/radiotherapy has thus far led to 13 live births, a serious risk might accompany this procedure. In a report published online in Blood, researchers believe that this method of fertility preservation might be unsafe for patients with leukemia. The risk is that the reimplanted tissue might harbor malignant cells that could induce disease recurrence. More

Killer T-cells, the fix for organ rejection?
New Scientist magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A convenient type of killer white blood cell could make organ rejection a thing of the past. The cells suppress the immune response in the livers of mice, without affecting the rest of the immune system. Humans have this type of blood cell, so it might be possible to create immune-tolerant organs for transplant. More

Researchers discover cause of immune system
avoidance of certain pathogens

Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A special set of sugars found on some disease-causing pathogens helps those pathogens fight the body's natural defenses as well as vaccines, say two Iowa State University researchers. This discovery may be a first step in understanding a disease family that includes tuberculosis for which there are currently no good vaccines or cures. Nicola Pohl, professor of chemistry, and Christine Petersen, assistant professor of veterinary pathology, discovered that a natural coating of sugar interacts with the body's defense cells to dampen its own immune response. Their findings are published in the current online issue of the Journal of the American Chemical Society. More

Multiple myeloma: Laboratory testing for plasma cell proliferative processes
Clinical Laboratory News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although it's not widely known today, multiple myeloma was the first disease for which the clinical laboratory could measure a quantifiable tumor marker, the Bence Jones protein. First described in 1847 by the English physician Henry Bence Jones and later characterized as a monoclonal free immunoglobulin light chain (mFLC), the Bence Jones protein and related monoclonal protein markers are invaluable for detecting, classifying, staging, and monitoring multiple myeloma. More

Bio-Rad's MRSASelect™ - Results on Your Time

Chromogenic Medium for Screening MRSA
With high sensitivity and specificity, this test can identify MRSA carriers in just 18–28 hours. The test procedure is simple, and results are easy to read and interpret. 

Newly identified RNA sequence is key in microRNA processing
Science Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Tufts University School of Medicine and Tufts Medical Center have identified an RNA sequence that promotes increased numbers of specific microRNAs (miRNAs), molecules that regulate cell growth, development, and stress response. The discovery helps researchers understand the links between miRNA expression and disease, including heart disease and cancer. More

Pesticide exposure linked to ADHD risk
WebMD Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail
Exposure in the womb to pesticides known as organophosphates may increase the chance that children, especially boys, will develop attention problems by age 5, a study shows. The research is published in Environmental Health Perspectives. Researchers followed more than 300 children who took part in the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) study. It was designed to look at how exposure to organophosphate pesticides affects reproductive health. More
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Jonathan Berger, Director of Advertising Sales

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • Dedicated - Helmer August 2010
  • Aug. 17, 2010
  • Aug. 10, 2010
  • Aug. 3, 2010
  • July 27, 2010
  •  RSS Feed
    Most popular articles